Sign Up to like & get
recommendations!
2
Published in 2023 at "Advanced healthcare materials"
DOI: 10.1002/adhm.202300944
Abstract: Brachytherapy, including radioactive seed implantation (RSI) and transarterial radiation therapy embolization (TARE), is an important treatment modality for advanced hepatocellular carcinoma (HCC), but the inability of RSI and TARE to treat tumor metastasis and recurrence…
read more here.
Keywords:
immunotherapy;
hepatocellular carcinoma;
rsi;
radio immunotherapy ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "ACS nano"
DOI: 10.1021/acsnano.2c04982
Abstract: Biomaterial-based pleiotropic immune activation may effectively improve the response rate of immunotherapy and enhance the therapeutic effect of the tumor. Bacteria as a natural carrier have demonstrated great advantages in tumor targeted delivery and immune…
read more here.
Keywords:
pleiotropic;
immunotherapy;
bacterial vectors;
radio immunotherapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.615697
Abstract: During the last years, preclinical and clinical studies have emerged supporting the rationale to integrate radiotherapy and immunotherapy. Radiotherapy may enhance the effects of immunotherapy by improving tumor antigen release, antigen presentation, and T-cell infiltration.…
read more here.
Keywords:
radio immunotherapy;
guided radiotherapy;
immunotherapy;
radiotherapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12051027
Abstract: Introduction: Curatively intended chemo-radio-immunotherapy for non-small cell lung cancer (NSCLC) stage III may lead to post-therapeutic pulmonary function (PF) impairment. We hypothesized that the decrease in global PF corresponds to the increase in tissue density…
read more here.
Keywords:
chemo radio;
non small;
dlco;
radio immunotherapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "International Journal of Oncology"
DOI: 10.3892/ijo.2018.4364
Abstract: CD44v6 is overexpressed in a variety of cancers, rendering it a promising target for radio-immunotherapy (RIT). In this study, we have characterized a novel engineered recombinant monoclonal anti-CD44v6 antibody, AbN44v6, and assessed its potential for…
read more here.
Keywords:
radio immunotherapy;
cd44v6;
antibody;
abn44v6 ... See more keywords